Neumora Therapeutics 2025 Financial Update
NMRA|EPS -$0.35|Net Loss $59.4M Neumora Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation therapies for brain diseases. Based ...
Sunday, September 13, 2026
Tag: Neumora
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.